Metalloproteinase mediated occludin cleavage in the cerebral microcapillary endothelium under pathological conditions

Brain Research

Volumn 1326, Issue , 2010, Pages 114-127

  Lischper, Mira ^a   Beuck, Simon ^a   Thanabalasundaram, Gokulan ^a   Pieper, Christian ^a   Galla, Hans Joachim ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Blood brain barrier; Cerebral ischemia reperfusion; Claudin 5; Hydrogen peroxide; Matrix metalloproteinase; Occludin

Indexed keywords

CLAUDIN 5; GELATINASE A; GELATINASE B; HYDROGEN PEROXIDE; ILOMASTAT; OCCLUDIN;

ANIMAL CELL; ARTICLE; AUTOREGULATION; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; CAPILLARY ENDOTHELIUM; CELL DEATH; CONTROLLED STUDY; ENDOTHELIUM LESION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS; SWINE;

ANALYSIS OF VARIANCE; ANIMALS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; COLLAGENASES; DIPEPTIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC IMPEDANCE; ENDOTHELIAL CELLS; ENDOTHELIUM; ENZYME INHIBITORS; HUMANS; HYDROGEN PEROXIDE; MATRIX METALLOPROTEINASE 2; MEMBRANE PROTEINS; OXIDANTS; SWINE;

SUS;

EID: 77950048543     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.02.054     Document Type: Article

References (52)

1. Aberdeen G.W., Wiegand S.J., Bonagura Jr. T.W., Pepe G.J., and Albrecht E.D. Vascular endothelial growth factor mediates the estrogen-induced breakdown of tight junctions between and increase in proliferation of microvessel endothelial cells in the baboon endometrium. Endocrinology 149 (2008) 6076-6083
2. Adibhatla R.M., and Hatcher J.F. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies. CNS Neurol. Disord. Drug Targets 7 (2008) 243-253
3. Anderson J.M., and Van Itallie C.M. Tight junctions and the molecular basis for regulation of paracellular permeability. Am. J. Physiol. 269 (1995) G467-G475
4. Ando-Akatsuka Y., Saitou M., Hirase T., Kishi M., Sakakibara A., Itoh M., Yonemura S., Furuse M., and Tsukita S. Interspecies diversity of the occludin sequence: cDNA cloning of human, mouse, dog, and rat-kangaroo homologues. J. Cell Biol. 133 (1996) 43-47
5. Andreeva A.Y., Krause E., Muller E.C., Blasig I.E., and Utepbergenov D.I. Protein kinase C regulates the phosphorylation and cellular localization of occludin. J. Biol. Chem. 276 (2001) 38480-38486
6. Bamforth S.D., Kniesel U., Wolburg H., Engelhardt B., and Risau W. A dominant mutant of occludin disrupts tight junction structure and function. J. Cell Sci. 112 Pt 12 (1999) 1879-1888
7. Bojarski C., Weiske J., Schoneberg T., Schroder W., Mankertz J., Schulzke J.D., Florian P., Fromm M., Tauber R., and Huber O. The specific fates of tight junction proteins in apoptotic epithelial cells. J. Cell Sci. 117 (2004) 2097-2107
8. Candelario-Jalil E., Yang Y., and Rosenberg G.A. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia. Neuroscience 158 3 (2008) 983-994
9. Chang D.I., Hosomi N., Lucero J., Heo J.H., Abumiya T., Mazar A.P., and del Zoppo G.J. Activation systems for latent matrix metalloproteinase-2 are upregulated immediately after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 23 (2003) 1408-1419
10. Crack P.J., Taylor J.M., de Haan J.B., Kola I., Hertzog P., and Iannello R.C. Glutathione peroxidase-1 contributes to the neuroprotection seen in the superoxide dismutase-1 transgenic mouse in response to ischemia/reperfusion injury. J. Cereb. Blood Flow Metab. 23 (2003) 19-22
11. Dorfel M.J., Westphal J.K., and Huber O. Differential phosphorylation of occludin and tricellulin by CK2 and CK1. Ann. N. Y. Acad. Sci. 1165 (2009) 69-73
12. Elias B.C., Suzuki T., Seth A., Giorgianni F., Kale G., Shen L., Turner J.R., Naren A., Desiderio D.M., and Rao R. Phosphorylation of Tyr-398 and Tyr-402 in occludin prevents its interaction with ZO-1 and destabilizes its assembly at the tight junctions. J. Biol. Chem. 284 (2009) 1559-1569
13. Fert-Bober J., Leon H., Sawicka J., Basran R.S., Devon R.M., Schulz R., and Sawicki G. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion. Basic Res. Cardiol. 103 (2008) 431-443
14. Gasche Y., Copin J.C., Sugawara T., Fujimura M., and Chan P.H. Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 21 (2001) 1393-1400
15. Graham A., Ford I., Morrison R., Barker R.N., Greaves M., and Erwig L.P. Anti-endothelial antibodies interfere in apoptotic cell clearance and promote thrombosis in patients with antiphospholipid syndrome. J. Immunol. 182 (2009) 1756-1762
16. Ishizaki T., Chiba H., Kojima T., Fujibe M., Soma T., Miyajima H., Nagasawa K., Wada I., and Sawada N. Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates and expression of claudin-5 gene in blood-brain-barrier endothelial cells via protein kinase A-dependent and -independent pathways. Exp. Cell Res. 290 2 (2003) 275-288
17. Kevil C.G., Oshima T., Alexander B., Coe L.L., and Alexander J.S. H(2)O(2)-mediated permeability: role of MAPK and occludin. Am. J. Physiol. Cell Physiol. 279 (2000) C21-C30
18. Kondo T., Kinouchi H., Kawase M., and Yoshimoto T. Differential response in the release of hydrogen peroxide between astroglial cells and endothelial cells following hypoxia/reoxygenation. Neurosci. Lett. 215 (1996) 103-106
19. Kroll S., El-Gindi J., Thanabalasundaram G., Panpumthong P., Schrot S., Hartmann C., and Galla H.J. Control of the blood-brain barrier by glucocorticoids and the cells of the neurovascular unit. Ann. N. Y. Acad. Sci. 1165 (2009) 228-239
20. Lee S.R., and Lo E.H. Interactions between p38 mitogen-activated protein kinase and caspase-3 in cerebral endothelial cell death after hypoxia-reoxygenation. Stroke 34 (2003) 2704-2709
21. Li Q., Zhang Q., Wang C., Liu X., Qu L., Gu L., Li N., and Li J. Altered distribution of tight junction proteins after intestinal ischemia/reperfusion injury in rats. J. Cell. Mol. Med. 13 (2009) 4061-4076
22. Liu W., Hendren J., Qin X.J., Shen J., and Liu K.J. Normobaric hyperoxia attenuates early blood-brain barrier disruption by inhibiting MMP-9-mediated occludin degradation in focal cerebral ischemia. J. Neurochem. 108 (2009) 811-820
23. Lohmann C., Krischke M., Wegener J., and Galla H.J. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways. Brain Res. 995 (2004) 184-196
24. Lu L., Tonchev A.B., Kaplamadzhiev D.B., Boneva N.B., Mori Y., Sahara S., Ma D.X., Nakaya M., Kikuchi M., and Yamashima T. Expression of matrix metalloproteinases in the neurogenic niche of the adult monkey hippocampus after ischemia. Hippocampus 18 (2008) 1074-1084
25. Manoonkitiwongsa P.S., Jackson-Friedman C., McMillan P.J., Schultz R.L., and Lyden P.D. Angiogenesis after stroke is correlated with increased numbers of macrophages: the clean-up hypothesis. J. Cereb. Blood Flow Metab. 21 (2001) 1223-1231
26. Marco S., and Skaper S.D. Amyloid beta-peptide1-42 alters tight junction protein distribution and expression in brain microvessel endothelial cells. Neurosci. Lett. 401 3 (2006) 219-224
27. McMahon S., Grondin F., McDonald P.P., Richard D.E., and Dubois C.M. Hypoxia-enhanced expression of the proprotein convertase furin is mediated by hypoxia-inducible factor-1: impact on the bioactivation of proproteins. J. Biol. Chem. 280 (2005) 6561-6569
28. Ohab J.J., Fleming S., Blesch A., and Carmichael S.T. A neurovascular niche for neurogenesis after stroke. J. Neurosci. 26 (2006) 13007-13016
29. Pober J.S., Min W., and Bradley J.R. Mechanisms of endothelial dysfunction, injury, and death. Annu. Rev. Pathol. 4 (2009) 71-95
30. Reijerkerk A., Kooij G., van der Pol S.M., Khazen S., Dijkstra C.D., and de Vries H.E. Diapedesis of monocytes is associated with MMP-mediated occludin disappearance in brain endothelial cells. FASEB J. 20 (2006) 2550-2552
31. Rosenberg G.A. Matrix metalloproteinases in brain injury. J. Neurotrauma 12 (1995) 833-842
32. Rosenberg G.A., Estrada E.Y., and Dencoff J.E. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 29 (1998) 2189-2195
33. Rosenberg G.A., and Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg. Focus 22 (2007) E4
34. Sakakibara A., Furuse M., Saitou M., Ando-Akatsuka Y., and Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. J. Cell Biol. 137 (1997) 1393-1401
35. Schreibelt G., Kooij G., Reijerkerk A., van Doorn R., Gringhuis S.I., van der Pol S., Weksler B.B., Romero I.A., Couraud P.O., Piontek J., Blasig I.E., Dijkstra C.D., Ronken E., and de Vries H.E. Reactive oxygen species alter brain endothelial tight junction dynamics via RhoA, PI3 kinase, and PKB signaling. FASEB J. 21 (2007) 3666-3676
36. Seltzer J.L., Akers K.T., Weingarten H., Grant G.A., McCourt D.W., and Eisen A.Z. Cleavage specificity of human skin type IV collagenase (gelatinase). Identification of cleavage sites in type I gelatin, with confirmation using synthetic peptides. J. Biol. Chem. 265 (1990) 20409-20413
37. Slevin M., and Krupinski J. Cyclin-dependent kinase-5 targeting for ischaemic stroke. Curr. Opin. Pharmacol. 9 (2009) 119-124
38. Stamatovic S.M., Keep R.F., Wang M.M., Jankovic I., and Andjelkovic A.V. Caveolae-mediated internalization of occludin and claudin-5 during CCL2-induced tight junction remodeling in brain endothelial cells. J. Biol. Chem. 284 28 (2009) 19053-19066
39. Sternlicht M.D., and Werb Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell Dev. Biol. 17 (2001) 463-516
40. Sundstrom J.M., Tash B.R., Murakami T., Flanagan J.M., Bewley M.C., Stanley B.A., Gonsar K.B., and Antonetti D.A. Identification and analysis of occludin phosphosites: a combined mass spectrometry and bioinformatics approach. J. Proteome Res. 8 (2009) 808-817
41. Suzuki T., Elias B.C., Seth A., Shen L., Turner J.R., Giorgianni F., Desiderio D., Guntaka R., and Rao R. PKC eta regulates occludin phosphorylation and epithelial tight junction integrity. Proc. Natl. Acad. Sci. U. S. A. 106 1 (2009) 61-66
42. Tagaya M., Haring H.P., Stuiver I., Wagner S., Abumiya T., Lucero J., Lee P., Copeland B.R., Seiffert D., and del Zoppo G.J. Rapid loss of microvascular integrin expression during focal brain ischemia reflects neuron injury. J. Cereb. Blood Flow Metab. 21 (2001) 835-846
43. Takenaga Y., Takagi N., Murotomi K., Tanonaka K., and Takeo S. Inhibition of Src activity decreases tyrosine phosphorylation of occludin in brain capillaries and attenuates increase in permeability of the blood-brain barrier after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab. 29 (2009) 1099-1108
44. Tsukita S., and Furuse M. Occludin and claudins in tight-junction strands: leading or supporting players?. Trends Cell Biol. 9 (1999) 268-273
45. Valentin F., Bueb J.L., Kieffer P., Tschirhart E., and Atkinson J. Oxidative stress activates MMP-2 in cultured human coronary smooth muscle cells. Fundam. Clin. Pharmacol. 19 (2005) 661-667
46. Vannini N., Pfeffer U., Lorusso G., Noonan D.M., and Albini A. Endothelial cell aging and apoptosis in prevention and disease: E-selectin expression and modulation as a model. Curr. Pharm. Des. 14 (2008) 221-225
47. Wachtel M., Frei K., Ehler E., Fontana A., Winterhalter K., and Gloor S.M. Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J. Cell Sci. 112 Pt 23 (1999) 4347-4356
48. Wang X., Rosell A., and Lo E.H. Targeting extracellular matrix proteolysis for hemorrhagic complications of tPA stroke therapy. CNS Neurol. Disord. Drug Targets 7 (2008) 235-242
49. Weisbrot-Lefkowitz M., Reuhl K., Perry B., Chan P.H., Inouye M., and Mirochnitchenko O. Overexpression of human glutathione peroxidase protects transgenic mice against focal cerebral ischemia/reperfusion damage. Brain Res. Mol. Brain Res. 53 (1998) 333-338
50. Witt K.A., Mark K.S., Sandoval K.E., and Davis T.P. Reoxygenation stress on blood-brain barrier paracellular permeability and edema in the rat. Microvasc. Res. 75 (2008) 91-96
51. Yamamoto M., Ramirez S.H., Sato S., Kiyota T., Cerny R.L., Kaibuchi K., Persidsky Y., and Ikezu T. Phosphorylation of claudin-5 and occludin by rho kinase in brain endothelial cells. Am. J. Pathol. 172 2 (2008) 521-533
52. Yang Y., Estrada E.Y., Thompson J.F., Liu W., and Rosenberg G.A. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J. Cereb. Blood Flow Metab. 27 (2007) 697-709